Sleep apnea is very common—more common than we know. The numbers paint an interesting story. Roughly 80 million U.S. adults and 10 million U.S. children suffer from obstructive sleep apnea—and approximately 85% of them are undiagnosed and untreated. The challenge is a sleep study can be costly and time intensive. But now, technology can help.
Roughly 30-50% of consumers are now embracing at-home diagnostics self-monitoring tools. One example is Vivos, which offers VivoScore. The Bluetooth-enabled finger ring and home sleep testing technology is FDA-cleared for patients as young as two years old.
Here is how this can help:
- Eliminates the need for overnight lab visits.
- Offers clinical-grade diagnostics at a fraction of the cost.
- Connections for sleep, test reads, diagnostics, and telemedicine consultations help patients receive accurate results and professional medical insights from their homes.
Looking to the future, we are going to see new technologies continue to emerge in the medical field. In the case of sleep apnea, new technologies will be able to help diagnose patients and make them more aware of their condition, helping reduce that 85% of people who are undiagnosed.